Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis).
We have previously reported a cynomolgus monkey (Macaca fascicularis) pedigree with early onset macular degeneration that develops drusen at 2 yr after birth. In this study, the molecular composition of drusen in monkeys affected with late onset and early onset macular degeneration was both characterized. Involvement of anti-retinalautoimmunity in the deposition of drusen and the pathogenesis of the disease was also evaluated. Funduscopic and histological examinations were performed on 278 adult monkeys (mean age=16.94 yr) for late onset macular degeneration. The molecular composition of drusen was analyzed by immunohistochemistry and/or direct proteome analysis using liquid chromatography tandem mass spectroscopy (LC-MS/MS). Anti-retinal autoantibodies in sera were screened in 20 affected and 10 age-matched control monkeys by Western blot techniques. Immunogenic molecules were identified by 2D electrophoresis and LC-MS/MS. Relative antibody titer against each antigen was determined by ELISA in sera from 42 affected (late onset) and 41 normal monkeys. Yellowish-white spots in the macular region were observed in 90 (32%) of the late onset monkeys that were examined. Histological examination demonstrated that drusen or degenerative retinal pigment epithelium (RPE) cells were associated with the pigmentary abnormalities. Drusen in both late and early onset monkeys showed immunoreactivities for apolipoprotein E, amyloid P component, complement component C5, the terminal C5b-9 complement complex, vitronectin, and membrane cofactor protein. LC-MS/MS analyses identified 60 proteins as constituents of drusen, including a number of common components in drusen of human age-related macular degeneration (AMD), such as annexins, crystallins, immunoglobulins, and complement components. Half of the affected monkeys had single or multiple autoantibodies against 38, 40, 50, and 60 kDa retinal proteins. The reacting antigens of 38 and 40 kDa were identified as annexin II and mu-crystallin, respectively. Relative antibody titer against annexin II in affected monkeys was significantly higher than control animals (P<0.01). Significant difference was not observed in antibody titer against mu-crystallin; however, several affected monkeys showed considerably elevated titer (360-610%) compared with the mean for unaffected animals. Monkey drusen both in late and early onset forms of macular degeneration had common components with drusen in human AMD patients, indicating that chronic inflammation mediated by complement activation might also be involved in the formation of drusen in these affected monkeys. The high prevalence of anti-retinalautoantibodies in sera from affected monkeys demonstrated an autoimmune aspect of the pathogenesis of the disease. Although further analyses are required to determine whether and how autoantibodies against annexin II or mu-crystallin relate to the pathogenesis of the disease, it could be hypothesized that immune responses directed against these antigens might trigger chronic activation of the complement cascade at the site of drusen formation.
Umeda
Shinsuke
S
National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Meguro-ku, Tokyo, Japan.
Suzuki
Michihiro T
MT
Okamoto
Haru
H
Ono
Fumiko
F
Mizota
Atsushi
A
Terao
Keiji
K
Yoshikawa
Yasuhiro
Y
Tanaka
Yasuhiko
Y
Iwata
Takeshi
T
D000375:Aging; D000818:Animals; D017306:Annexin A2 / Q000737:chemistry; D001323:Autoantibodies / Q000737:chemistry; D001324:Autoantigens / Q000737:chemistry; D015551:Autoimmunity; D015153:Blotting, Western; D002478:Cells, Cultured; D002853:Chromatography, Liquid; D003167:Complement Activation; D003459:Crystallins / Q000737:chemistry; D004285:Dogs; D015180:Electrophoresis, Gel, Two-Dimensional; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008252:Macaca fascicularis; D008268:Macular Degeneration / Q000473:pathology*; D013058:Mass Spectrometry; D008856:Microscopy, Fluorescence; D008954:Models, Biological; D010857:Pigment Epithelium of Eye / Q000166:cytology; D040901:Proteomics; D012160:Retina / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D015593:Retinal Drusen / Q000235:genetics* / Q000378:metabolism; D013997:Time Factors; D000090803:mu-Crystallins
D017306:Annexin A2; D001323:Autoantibodies; D001324:Autoantigens; D003459:Crystallins; D000090803:mu-Crystallins